BIOQUÍMICA Y BIOLOGÍA MOLECULAR
Departamento
Rocío Isabel
Rodríguez Macías
Catedrática de Universidad
Publicaciones en las que colabora con Rocío Isabel Rodríguez Macías (58)
2024
2022
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
-
Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma
HEPATOBILIARY SURGERY AND NUTRITION
-
Liver and gastrointestinal cancers
DRUG EFFLUX PUMPS IN CANCER RESISTANCE PATHWAYS: FROM MOLECULAR RECOGNITION AND CHARACTERIZATION TO POSSIBLE INHIBITION STRATEGIES IN CHEMOTHERAPY (ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD), pp. 197-250
-
Molecular bases of drug resistance in hepatocellular carcinoma
Cancers, Vol. 12, Núm. 6, pp. 1-26
-
Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach
Cancers, Vol. 12, Núm. 6, pp. 1-30
-
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2018
-
Chemoprotective Role of Vitamin C in Liver Diseases
The Liver: Oxidative Stress and Dietary Antioxidants (Elsevier), pp. 139-153
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
2017
-
Molecular bases of chemoresistance in cholangiocarcinoma
Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900
2015
-
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)
Journal of Controlled Release, Vol. 216, pp. 93-102
2014
-
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10
2012
-
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta
Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427